AI in Medical
AI in Telemedicine and Digital Healthcare
Published Patent Application — India (App. No. 202541127477)PeachBot Med & MedAI+
Explore
Digital healthcare demands timely insights, secure data handling, and reliable system integration. PeachBot Med and MedAI+ leverage edge AI to support telemedicine workflows, remote patient monitoring, and interoperable medical device integration in distributed care environments.
Published Patent Application (India): PeachBot Med & MedAI+ incorporate proprietary system architectures for on-device clinical intelligence, privacy-preserving local processing, and telemedicine workflow integration. The core architectural framework has been published in the Official Patent Gazette under the Indian Patents Act (Application No. 202541127477 · Publication Date: 23 January 2026). The application is currently awaiting examination.
Overview
PeachBot Med & MedAI+ are next-generation AI-accelerated single board computers (SBCs) designed to transform modern healthcare delivery. Combining advanced AI analytics, telemedicine capabilities, and seamless device integration, the platform empowers hospitals, clinics, and digital medical centers to provide smarter, faster, and more secure patient care.
The platform enables remote patient monitoring, real-time diagnostics, and EMR integration, reducing operational complexity and improving clinical decision-making. With AI-driven insights, healthcare providers can predict patient deterioration, optimize resource allocation, and deliver personalized treatment plans remotely, enhancing patient outcomes.
Designed for scalability, PeachBot Med & MedAI+ support multi-device interoperability, integrating seamlessly with ECG monitors, vital sign sensors, imaging devices, and lab instruments. Edge AI processing ensures data is analyzed locally, minimizing latency, safeguarding sensitive health information, and Designed to support data protection requirements aligned with HIPAA , GDPR principles.
Clinicians benefit from automated workflows, intelligent reporting, and predictive alerts, which streamline consultations and administrative tasks. The compact SBC form factor makes deployment easy across hospitals, remote clinics, and home-care setups, while pre-configured software modules accelerate onboarding and reduce IT maintenance.
By bridging hardware, AI, and cloud services, PeachBot Med & MedAI+ transform conventional healthcare systems into intelligent, responsive, and efficient digital ecosystems. Providers can extend care to underserved regions, enable continuous patient monitoring, and harness data-driven insights to improve outcomes, operational efficiency, and patient satisfaction.
Intended Use
PeachBot Med & MedAI+ are intended to support digital healthcare workflows, device integration, data visualization, and clinical decision support for use by qualified healthcare professionals.
The platform is not intended to provide medical advice, diagnosis, or treatment recommendations, and does not replace licensed medical judgment or institutional clinical protocols.
This platform page is intended for research, academic collaboration, and institutional evaluation purposes.
Regulatory & Safety Notice: PeachBot Medical System is intended to support digital communication between healthcare professionals and their patients. It is not a substitute for professional medical judgment, diagnosis, or treatment. Use of the platform must comply with applicable healthcare regulations, professional practice guidelines, and data protection laws, including patient consent and privacy requirements.
Learn more about our AI foundations in biology and Blogs.
Research Commercialization Roadmap
A phased pathway outlining how research-led innovation may translate into regulated, real-world impact over time.
Stage 1
Research & Validation
Core system architectures, algorithms, and workflows are developed and validated through non-commercial research, prototyping, and controlled technical evaluations.
Stage 2
Pilot Studies & Institutional Evaluation
Selected platforms may undergo pilot studies and technical assessments in collaboration with academic institutions, research hospitals, and innovation programs.
Stage 3
Regulatory Readiness & Partnerships
Learnings from pilot studies inform regulatory readiness, compliance planning, and engagement with domain experts, healthcare institutions, and ecosystem partners.
Stage 4
Future Commercialization Pathways
Any future commercialization, if pursued, would occur through appropriately structured legal entities, subject to applicable regulations, institutional approvals, and jurisdictional requirements.
This roadmap is indicative and research-focused. It does not represent current commercial activity, sales, or deployment, and is presented solely to outline long-term innovation and translation pathways.
Frequently Asked Questions
Answers to common questions about PeachBot Med & MedAI+, telemedicine, clinical AI, and healthcare data security.
1. What is PeachBot Med & MedAI+?
PeachBot Med & MedAI+ are AI-accelerated telemedicine and healthcare intelligence platforms that support remote patient monitoring, device integration, EMR workflows, and secure clinical analytics.
2. Does PeachBot Med provide medical advice or diagnosis?
No. The platform does not provide medical advice, diagnosis, or treatment recommendations. It is intended to support qualified healthcare professionals with decision-support tools.
3. Which medical devices can be integrated?
PeachBot Med supports integration with ECG monitors, vital sign sensors, imaging systems, laboratory instruments, and other clinical devices.
4. How is patient data protected?
The platform uses edge AI processing, local data analysis, and secure workflows designed to align with HIPAA and GDPR principles, reducing latency and protecting sensitive health data.
5. Who should use PeachBot Med?
PeachBot Med & MedAI+ are intended for hospitals, clinics, digital medical centers, and qualified healthcare professionals involved in patient care and monitoring.
6. Is PeachBot Med a patented technology?
Yes. The core system architecture is covered under an Indian patent application published in the Official Patent Gazette under Section 11A of the Indian Patents Act (Application No. 202541127477). The application is currently awaiting examination.
Latest AI in Healthcare Trends
Discover the latest trends shaping the future
